
Sign up to save your podcasts
Or


Kirsten Detrick T’92 spent more than 30 years as an executive in the biopharma industry, working for firms such as Takeda, Amgen, and Bristol Myers Squibb. Detrick recently returned to Tuck to teach the mini course “Contemporary Issues in Biotechnology,” which is offered every year in the spring.
Detrick discusses her career, her course, and some of the most pressing challenges faced today in the biopharma space. Detrick uses her position as an adjunct professor to teach, coach, motivate, and inspire. As she explains in the conversation, biopharma is a business, “but unlike other businesses, it has humanity at the very core of what it’s about. The people who succeed, thrive and find themselves attracted to this industry are those who hear a higher calling and want to use business to address that higher calling.”
By Tuck School of BusinessKirsten Detrick T’92 spent more than 30 years as an executive in the biopharma industry, working for firms such as Takeda, Amgen, and Bristol Myers Squibb. Detrick recently returned to Tuck to teach the mini course “Contemporary Issues in Biotechnology,” which is offered every year in the spring.
Detrick discusses her career, her course, and some of the most pressing challenges faced today in the biopharma space. Detrick uses her position as an adjunct professor to teach, coach, motivate, and inspire. As she explains in the conversation, biopharma is a business, “but unlike other businesses, it has humanity at the very core of what it’s about. The people who succeed, thrive and find themselves attracted to this industry are those who hear a higher calling and want to use business to address that higher calling.”